4//SEC Filing
GARRETT J STEVEN 4
Accession 0001260651-04-000013
CIK 0000809875other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 2:29 PM ET
Size
8.8 KB
Accession
0001260651-04-000013
Insider Transaction Report
Form 4
GARRETT J STEVEN
Senior VP Clinical Research
Transactions
- Exercise/Conversion
Stock Option (Right-To-Buy)
2004-08-11$9.50/sh−5,000$47,500→ 0 totalExercise: $9.50From: 2001-08-03Exp: 2010-08-03→ Common Stock (5,000 underlying) - Sale
Common Stock, $.001 Par Value
2004-08-11$30.53/sh−5,000$152,650→ 3,500 total - Exercise/Conversion
Common Stock, $.001 Par Value
2004-08-11$9.50/sh+5,000$47,500→ 8,500 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeother
Related Parties
1- filerCIK 0001260651
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 2:29 PM ET
- Size
- 8.8 KB